Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04855773 · ClinicalTrials.gov registry record · NA

Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention

A NA study of HIV Infections and Sexually Transmitted Diseases, sponsored by Public Health Foundation Enterprises.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
4
Study locations

NCT04855773 is a NA study of HIV Infections and Sexually Transmitted Diseases that is actively recruiting participants, run by Public Health Foundation Enterprises. The registered enrollment target is 300 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (33% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04855773, a NA study of HIV Infections and Sexually Transmitted Diseases, is actively recruiting participants, sponsored by Public Health Foundation Enterprises.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to compare the effectiveness of two mobile health technologies (text messaging or a mobile app) designed to help people take HIV pre-exposure prophylaxis (PrEP) as directed by the clinic. PrEP is the use of a daily anti-HIV medications by HIV-negative people to help prevent HIV infection.

Interventions

  • OTHER PrEPmate
  • DEVICE Dot Diary

Study Locations (4)

California

  • Bridge HIV, San Francisco Department of Public Health - San Francisco
  • San Francisco AIDS Foundation - San Francisco

District of Columbia

  • Whitman-Walker Health - Washington D.C.

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2021-07-21
Est. Completion 2023-08
Phase NA

What the Registry Record Tells You About NCT04855773

The ClinicalTrials.gov registry entry for NCT04855773 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (33% lower). The listed sponsor is Public Health Foundation Enterprises, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which PrEPmate is the first listed.

NCT04855773 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, District of Columbia, Florida.

Frequently Asked Questions

What is clinical trial NCT04855773 about?

NCT04855773 is a clinical study titled "Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention". The purpose of this study is to compare the effectiveness of two mobile health technologies (text messaging or a mobile app) designed to help people take HIV pre-exposure prophylaxis (PrEP) as directed by the clinic. PrEP is the use of a daily anti-HIV medications by HIV-negative people to help prev...

What is the current status of trial NCT04855773?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2021-07-21. Estimated completion is 2023-08.

What conditions does trial NCT04855773 study?

This clinical trial studies the following conditions: HIV Infections, Sexually Transmitted Diseases.

What interventions are being tested in trial NCT04855773?

The interventions under investigation include: PrEPmate (OTHER), Dot Diary (DEVICE).

Who is sponsoring clinical trial NCT04855773?

This trial is sponsored by Public Health Foundation Enterprises, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04855773 being conducted?

This trial has 4 study locations across California, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.